Nucynta ER Has Been Approved for Treatment of Chronic Pain
If you suffer from chronic pain, you may be eligible to receive Social Security Disability benefits. Chronic pain is the leading cause of disability in the United States and Jansen Pharmaceuticals has announced that Nucynta ER (tapendidole extended release) has been approved by the Food and Drug Administration to treat moderate to severe chronic pain in adults. The most common side effects were nausea, constipation and dizziness and the extended release formulation will be of great benefit to chronic relief sufferers regardless of the side effects. Almost one third of Americans have chronic pain at some pain in their lives and it’s...
Continue reading